Drug Trial Radar · NCT00000479
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
Last checked: Nov 20, 2026Latest source record: Jun 15, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
39,876
Actual
Start
Sep 1992
Primary completion
Mar 2004
Study completion Feb 2005
Sponsor
- Lead sponsor
- Brigham and Women's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- Oct 28, 1999
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- Female only, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effects of low-dose aspirin and vitamin E in primary prevention of cardiovascular disease and cancer in apparently healthy women.
Conditions
- Cardiovascular Diseases
- Cerebrovascular Disorders
- Coronary Disease
- Heart Diseases
- Myocardial Infarction
- Myocardial Ischemia
- Vascular Diseases
Interventions
AspirinDrug
Participants will receive 100 mg of aspirin every other day.
Vitamin EDrug
Participants will receive 600 IU of vitamin E every other day.
PlaceboBehavioral
Participants will receive placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Major Cardiovascular Events (a Combined Endpoint of Nonfatal Myocardial Infarction, Nonfatal Stroke, and Total Cardiovascular Death)Time frame: Average follow-up 10.1 years
- Number of Participants With Cancer, Excluding Nonmelanoma Skin CancerTime frame: Average follow-up 10.1 years
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.